Benzinga | Nov 9, 2021 11:08AM EST

AVEO Pharmaceuticals Q3 EPS $(0.30) Beats $(0.36) Estimate, Sales $15.17M Beat $13.80M Estimate

AVEO Pharmaceuticals (NASDAQ:AVEO) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 9.09 percent increase over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $15.17 million which beat the analyst consensus estimate of $13.80 million by 9.95 percent. This is a 321.47 percent increase over sales of $3.60 million the same period last year.